R Trademark

Trademark Overview


On Friday, April 12, 2024, a trademark application was filed for R with the United States Patent and Trademark Office. The USPTO has given the R trademark a serial number of 79396229. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 29, 2025. This trademark is owned by Rejuvenate Biomed NV. The R trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medical, biological, and pharmaceutical preparations for the treatment of viral infections, bacterial infections, cancer, viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for pets, cattle, livestock, for the treatment of viral infections, bacterial infections, cancer, viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical, biological, and pharmaceutical preparations for preventing and treating viral, bacterial, and yeast infections; veterinary preparations for pets, cattl...

Biological research; clinical research in the field of age-related diseases and cancer; medical research; research and development services in the field of pharmaceutical preparations; pharmaceutical products development; pharmaceutical product evaluation; research and development in the field of microorganisms and cells; research on the subject of pharmaceuticals; testing of pharmaceuticals; laboratory research services relating to pharmaceutical product development; development of gene-based medicines; drug discovery services; scientific research in the nature of conducting clinical trials for others relating to pharmaceutical products; scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific risk assessment being consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following an accidental or terrorist caused release of ch...
r

General Information


Serial Number79396229
Word MarkR
Filing DateFriday, April 12, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, July 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 29, 2025

Trademark Statements


Description of MarkThe mark consists of a stick figure man with the body shown in dark blue and an orange circle as the head.
Goods and ServicesMedical, biological, and pharmaceutical preparations for the treatment of viral infections, bacterial infections, cancer, viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for pets, cattle, livestock, for the treatment of viral infections, bacterial infections, cancer, viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical, biological, and pharmaceutical preparations for preventing and treating viral, bacterial, and yeast infections; veterinary preparations for pets, cattle, livestock, for preventing and treating viral, bacterial, and yeast infections; medical, biological, and pharmaceutical preparations for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for pets, cattle, livestock for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; sanitary preparations for medical purposes; dietary supplements and dietetic preparations adapted for medical purposes; dietetic foods adapted for medical use; diagnostic preparations for medical purposes; diagnostic chemical reagents for medical use; clinical medical reagents
Indication of Colors claimedThe color(s) orange and dark blue is/are claimed as a feature of the mark.
Goods and ServicesBiological research; clinical research in the field of age-related diseases and cancer; medical research; research and development services in the field of pharmaceutical preparations; pharmaceutical products development; pharmaceutical product evaluation; research and development in the field of microorganisms and cells; research on the subject of pharmaceuticals; testing of pharmaceuticals; laboratory research services relating to pharmaceutical product development; development of gene-based medicines; drug discovery services; scientific research in the nature of conducting clinical trials for others relating to pharmaceutical products; scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific risk assessment being consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following an accidental or terrorist caused release of chemical, biological, radiological or nuclear materials; consulting services in the field of pharmaceutical research; testing of pharmaceuticals being services for assessing the efficiency of pharmaceuticals; pharmaceutical toxicity testing for research purposes; pharmaceutical toxicity analysis services for scientific research purposes; computer services, namely, remote management of the information technology (IT) systems of others for the pharmaceutical and healthcare industries; conducting early evaluations in the field of new pharmaceuticals; providing information about scientific research, namely, the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; chemical research and analysis services; medical and pharmacological research services; scientific services, namely, scientific research in the field of genetics; scientific research for medical purposes in the field of age-related diseases and cancer; medical and scientific research, namely, conducting clinical trials for others; scientific research in the field of genetics; genetic mapping for scientific purposes; DNA screening for scientific research purposes; providing scientific research information in the field of pharmaceuticals for the treatment of medical disorders; technical research in the field of pharmaceutical studies; veterinary research; design and development of computer software relating to the medical field; design and development of computer software relating to healthcare; computer programming in the medical field; scientific computer programming services; providing temporary use of non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; providing temporary use of on-line non-downloadable computer programs on data networks using artificial intelligence (AI) for use in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; platform as a service (PAAS) featuring computer software platforms using artificial intelligence (AI) for use in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) services featuring software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) featuring software using artificial intelligence (AI) for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) featuring software using artificial intelligence (AI) for analysis of self-assessment of illnesses; software as a service (SaaS) featuring software using artificial intelligence (AI) for machine learning in the field of healthcare; software as a service (SaaS) featuring health monitoring software; software as a service (SaaS) featuring software for analyzing biological genetic data; technology consultation in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI)

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 23, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRejuvenate Biomed NV
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE

Party NameRejuvenate Biomed NV
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressBE

Party NameRejuvenate Biomed NV
Party Type10 - Original Applicant
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Trademark Events


Event DateEvent Description
Thursday, May 23, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, June 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 3, 2024APPLICATION FILING RECEIPT MAILED
Friday, October 25, 2024ASSIGNED TO EXAMINER
Tuesday, October 29, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 30, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 5, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 5, 2024REFUSAL PROCESSED BY MPU
Friday, November 8, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, November 23, 2024REFUSAL PROCESSED BY IB
Friday, March 28, 2025NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 1, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 1, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 20, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 23, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 29, 2025PUBLISHED FOR OPPOSITION
Tuesday, July 29, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, May 1, 2025TEAS/EMAIL CORRESPONDENCE ENTERED